Keynote
Allon Bloch is the co-founder and CEO of K Health, the clinical AI-powered primary care company on a mission to get everyone access to high-quality, affordable healthcare. Before starting K Health, Allon was the co-CEO of Wix and co-founder and CEO of Vroom, and also worked as a consultant at McKinsey & Co.
Speakers
Dr. Schiff joined Aisling in 2000 and serves as one of the Managing Partners. Prior to Aisling, Dr. Schiff practiced internal medicine for six years at the New York Presbyterian Hospital, where he maintains his position as a Clinical Assistant Professor of Medicine.
Dr. Schiff currently serves as a director of Aclaris Therapeutics, Dren Bio, and Monte Rosa Therapeutics. Additionally, Dr. Schiff serves as a board observer of Antios Therapeutics and Prolacta Biosciences. His prior board service includes Adams Respiratory Therapeutics (acquired by Reckitt Benckiser), Agile Therapeutics, ArgiNOx Pharmaceuticals, ARMGO Pharma, Barrier Therapeutics (acquired by Stiefel Laboratories), Bioenvision (acquired by Genzyme), CardioKine (acquired by Cornerstone), Cempra Pharmaceuticals, F2G, Harmony Biosciences, Miramar Labs (acquired by Sientra), Myogen (acquired by Gilead Sciences), PowerVision (acquired by Alcon), Quintiles (now IQVIA), SkinMedica (acquired by Allergan), Sirion Therapeutics (licenses acquired by Alcon), TransEnterix, Zavante Therapeutics (acquired by Nabriva) and ZELTIQ Aesthetics (acquired by Allergan). He is a longtime supporter and board member of the Visiting Nurse Service of New York.
Dr. Schiff received his M.D. from Cornell University Medical College, his M.B.A. from Columbia Business School, and his B.S. with honors in Neuroscience from Brown University.
Ilan Danieli has served as Precipio’s CEO since founding the company in early 2011. With over 20 years managing small and medium-size companies, some of his previous experiences include COO of Osiris, a publicly-traded company based in New York City with operations in the US, Canada, Europe; Laurus Capital Management, a multi-billion dollar hedge fund; and in various other entrepreneurial ventures. Ilan holds an MBA from the Darden School at the University of Virginia, and a BA in Economics from Bar-Ilan University in Israel. Ilan has a private pilot license, plays the saxophone, and possesses infinite love for his horses.
Dr. Jeff Wessler is a board-certified cardiologist and the founder and CEO of Heartbeat Health, the nation’s largest virtual-first cardiology company. Under his leadership, Heartbeat Health has expanded its reach across all 50 U.S. states, partnering with health plans, primary care groups, and employers to provide accessible cardiovascular care through telehealth and remote diagnostics. The company’s innovative approach has earned recognition, including a spot on the 2025 Inc. 5000 list of America’s fastest-growing private companies. Heartbeat Health has most recently raised a Series C funding round of $25,000,000 in July 2024.
Across all areas of his work, Dr. Wessler has accelerated the national adoption of virtual cardiology by designing, testing, and operationalizing care models that deliver measurable improvements in access and outcomes. Through a combination of academic research, large-scale clinical leadership, and public engagement, he has helped shape the conversation and direction of cardiovascular care delivery nationwide.
Moderators
Sponsors
Attendees
